Why A2 Milk shares and this mid cap ASX share could be buys

The broker has could things to say about these shares.

| More on:
A woman presenting company news to investors looks back at the camera and smiles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of ASX shares out there for investors to choose from, but two that come highly rated by analysts at Macquarie Group Ltd (ASX: MQG) are named below.

Here's why the broker is bullish on these names and tipping them as buys in March.

A2 Milk Company Ltd (ASX: A2M)

Infant formula company A2 Milk gets the thumbs up from Macquarie. It remains positive on A2 Milk shares despite its price target being largely in line with its current share price.

This is because the broker believes there are potential catalysts on the horizon that could drive a meaningful re-rating of the infant formula company's shares in the near future. It explains:

While A2M has re-rated strongly post-result and on China-stimulus news, key catalysts will be further earnings upgrades, success of recent product innovation, capital management, and supply-chain investment increasing China market access.

Its analysts currently have an outperform rating and $7.85 price target on the company's shares.

GQG Partners Inc (ASX: GQG)

As well as A2 Milk shares, Macquarie is tipping investment company GQG Partners as one to buy this month.

The broker highlights that GQG Partners' four investment strategies have been narrowed down from thousands of potential strategies. This helps explain how the company continues to perform so positively. It said:

At the 1H25 result GQG provided an overview of performance. The hurdles were set by GQG. GQG screened: #1) 6,641 strategies; #2) compared the 62% with a 10yrplus track record; #3) cut the list down to the 1.72% with positive excess return in 100% of 5-yr rolling periods, on a 1-mth shift; #4) looked for low volatility, beta <=0.8 vs benchmark; and #5) combined with downside risk management, measured by positive excess return in each major downturn period, MSCI ACWI Net Index declined by 10%+, over the prior decade (3Q2015 energy, 4Q2018 China, 1Q2020 COVID, and 1Q2022-3Q2022 Russia and rates). While the hurdles were set by GQG, only 4 strategies remained, or 0.06% of the total. All 4 were GQG primary strategies.

Unlike A2 Milk shares, Macquarie sees significant potential returns from where GQG Partners trades today. Its analysts have an outperform rating and $3.00 price target on the investment company's shares. This suggests that upside of 35% is possible from current levels.

The broker is also expecting a huge 10% dividend yield over the next 12 months, boosting the total potential return to approximately 45%.

Motley Fool contributor James Mickleboro has positions in Gqg Partners. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended A2 Milk and Gqg Partners. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman sets flowers on a side table in a beautifully furnished bedroom.
Broker Notes

Up 75% this year, does JP Morgan see further upside for Temple & Webster shares?

Can this high-flying ASX retailer keep rising?

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Initiation: Bell Potter just put a buy rating on this ASX 200 blue chip share

This blue chip has received a buy recommendation from the top broker.

Read more »

People sitting in rows in a meeting with one person holding their hand up as if to ask a question.
Broker Notes

Macquarie names 3 ASX All Ords stocks to deliver the most negative earnings surprises during AGM season

Macquarie expects these three stocks to disappoint during their AGMs.

Read more »

Retired couple hugging and laughing.
Broker Notes

Why Macquarie expects this $2.5 billon ASX healthcare share to rocket 36%

Macquarie forecasts strong outperformance for this ASX healthcare share.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Ord Minnett names 2 ASX 200 shares to buy

These shares have been given the thumbs up from the broker.

Read more »

Woman relaxing on her phone on her couch, symbolising passive income.
Broker Notes

2 quality ASX 200 shares tipped to outperform

Leading experts say these two ASX 200 shares are on the growth path.

Read more »

Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Does Macquarie prefer Medibank Private or NIB shares?

Let's see what the broker thinks of these two blue chips.

Read more »